{"url_path":"/sec/ew/8-k/2026-05-08/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1099800/0001099800-26-000028-index.html","accession_number":"0001099800-26-000028","cik":"0001099800","ticker":"EW","issuer_name":"Edwards Lifesciences Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1099800/0001099800-26-000028-index.html","primary_entity_key":"0001099800","primary_entity_name":"Edwards Lifesciences Corp"},"word_count":101,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits\n\n(d)    Exhibits.\n\nExhibit No.Description\n\n10.1\n[Amended and Restated Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program (incorporated by reference to Appendix](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001099800/000109980026000015/ew-20260326.htm#i9a242c701c8f4d75af78d94e92ffc3e8_244)[B](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001099800/000109980026000015/ew-20260326.htm#i9a242c701c8f4d75af78d94e92ffc3e8_244)[to Edwards’ Definitive Proxy Statement, filed March 26, 2026)](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001099800/000109980026000015/ew-20260326.htm#i9a242c701c8f4d75af78d94e92ffc3e8_244)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\n3\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nEDWARDS LIFESCIENCES CORPORATION\n\nBy:/s/ Linda J. Park\n\nLinda J. Park\n\nDate: May 8, 2026Senior Vice President, Associate General Counsel, and Corporate Secretary\n\n4"}